News
Lipoprotein(a) levels can guide CV risk assessment and treatment
June 5, 2019
High levels of Lp(a) are an independent risk factor for atherosclerotic cardiovascular disease and could be used to guide risk assessment and treatment.
![1]()
News
DOACs surpass warfarin in low-weight AFib patients
June 5, 2019
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.
![1]()
News
Restrictive transfusion strategy in cardiac surgery remains noninferior
May 24, 2019
Does using a restrictive transfusion strategy with patients undergoing cardiac surgery affect long-term outcomes?
News
AFib on the rise in end-stage COPD patients hospitalized for exacerbations
May 18, 2019
The prevalence of AFib among patients with end-stage COPD on home oxygen who were admitted with COPD exacerbations increased from 12.9% in 2003 to 21.3% in 2014.
![1]()
News
Add magnesium to treatment of AF with rapid ventricular response
May 16, 2019
Is magnesium a useful addition to atrioventricular (AV) nodal blockers in achieving faster rate control for atrial fibrillation (AF) with rapid ventricular response in emergency department patients?
![1]()
News
Aspirin shows little benefit for primary prevention of vascular disease in diabetes
May 15, 2019
Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?
News
Severe OSA increases cardiovascular risk after surgery
May 14, 2019
General anesthetics, sedatives, and postoperative analgesics are potent respiratory depressants that relax the upper airway dilator muscles and impair ventilatory response to hypoxemia and hypercapnia.
![1]()
News
AFib screening cuts hospitalizations and ED visits
May 11, 2019
NEW ORLEANS – People diagnosed with atrial fibrillation by screening had fewer hospitalizations and ED visits than those diagnosed by usual care.
![1]()
News
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
May 9, 2019
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.
![1]()
News
Quick Byte: Hope for HF patients
May 8, 2019
Device shows promise for heart failure patients.
